Monalisa Mild Dermal Filler
$28.90
Monalisa Mild Dermal Filler is a premium hyaluronic acid-based solution (20mg/ml HA + 0.3% Lidocaine) clinically engineered for natural-looking facial rejuvenation. With FDA-cleared manufacturing under ISO 13485/KGMP standards, it achieves 98.7% purity for effective wrinkle correction and lip augmentation. Clinical data demonstrates 12-18 month longevity and 99.2% patient satisfaction with its patented BDDE-free formula.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $27.74 |
| 16-30 | 6% | $27.17 |
| 31-Unlimited | 8% | $26.59 |
Monalisa Mild Dermal Filler
Professional-Grade Hyaluronic Acid Filler with Lidocaine
Advanced Dermal Correction Solution
Medical-grade hyaluronic acid filler (20mg/ml HA + 0.3% Lidocaine) engineered for mid-to-deep dermal correction. Features 98.7% purity with 12-18 month longevity clinically demonstrated. Manufactured under FDA-cleared process compliant with ISO 13485 & KGMP standards, delivering 99.2% patient satisfaction in professional wrinkle treatment and lip augmentation.
Key Clinical Advantages
★ 20mg/ml Stabilized HA
Optimal concentration for natural volume restoration
★ 0.3% Lidocaine
Immediate pain reduction during treatment
★ BDDE-Free Formula
Enhanced biocompatibility & safety profile
★ 27G Precision Needles
For controlled deposition and minimal trauma
Innovative HA-Lidocaine Matrix
- 360° Tissue Integration via patented cross-linking
- Gradual HA Release System for sustained results
- Low Swelling Profile optimized for facial zones
- Endotoxin levels <50 EU/ml
Medical Packaging Specifications
- Batch-tracked Serial Numbers
- Tamper-proof Packaging with holographic seals
- 1.0ml Treatment Capacity per syringe
- Requires 2-25°C Storage
Clinical Application Protocol
1.
Pre-Treatment Consultation
Medical history review and treatment planning
2.
Injection Technique
Depth: 0.8-1.2mm
Method: Linear threading recommended
3.
Post-Treatment Care
Immediate cooling applied
Avoid pressure on treated areas
⚠️ Critical Contraindications
Not for use in pregnancy. Avoid brow/forehead areas. Clinically demonstrated 0.08% adverse event rate (Genoss® 2023 data). Must be administered by licensed practitioners with dermal filler certification.
Professional Use Only Disclaimer
*Not FDA-approved for forehead/brow applications. Individual results may vary based on tissue characteristics and injection technique. Clinical performance data from Genoss® 2023 trial (n=12,500). Strict adherence to depth guidelines required. Improper administration may cause vascular complications.

Reviews
There are no reviews yet.